Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Immune Checkpoints: Targets, Resistance, and Future Therapies
Immune checkpoint inhibitors targeting pathways like PD-1/PD-L1 and CTLA-4 have revolutionized cancer immunotherapy.These pathways regulate T cell responses, and their blockade can restore anti-tumor immunity. Challenges include tumor microenvironment modulation, resistance mechanisms, and the need for better predictive biomarkers. Emerging checkpo... Read More»
: Immunol Curr Res
10.4172/icr.1000275Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals